iota Biosciences, Inc. powered by Astellas

is a biotechnology startup based in the United States, founded in 2017. The company is a subsidiary of Astellas Pharma US and focuses on developing innovative bioelectronics to advance the treatment and management of diseases. Their flagship product is based on award-winning ultrasound technology invented at the University of California, Berkeley. The company's mission is to create state-of-the-art diagnostic and therapeutic bioelectronic devices that are both safe and effective, ultimately aiming to transform the way diseases are managed and treated. In December 2018, iota Biosciences received a $15.00M Series A investment from a group of prominent investors including Ironfire Ventures, The House Fund, Horizons Ventures, Bold Capital Partners, Berkeley SkyDeck Fund, Astellas Pharma, and Shanda Group. The partnership with Astellas Pharma provides the company with experience, reach, and rigor to pursue their transformational vision and commitment to bringing greater value to patients. With a focus on groundbreaking bioelectronic technologies, iota Biosciences aims to bring life-changing innovations to patients and improve human life through its cutting-edge approaches in the medical device industry.